ChemInform Abstract: Design, Synthesis and Biological Evaluation of New 3‐[(4‐Aryl)piperazin‐1‐yl]‐1‐arylpropane Derivatives as Potential Antidepressants with a Dual Mode of Action: Serotonin Reuptake Inhibition and 5‐HT1A Receptor Antagonism. | Publicación